FDA

Three-judge panel in U.S. appeals court hears arguments in abortion pill case

BY: and - May 17, 2023

NEW ORLEANS — A federal appeals court panel quizzed lawyers during oral arguments Wednesday over a Texas judge’s decision that could end access to the abortion pill nationwide. Observers see the 5th Circuit Court of Appeals as a legal way station for the case, in which anti-abortion groups sued the U.S. Food and Drug Administration, […]

Arguments on landmark abortion pill case to be heard Wednesday in appeals court

BY: - May 16, 2023

WASHINGTON — The lawsuit over access to the abortion pill goes before the 5th Circuit Court of Appeals in New Orleans on Wednesday, the next step on a path that will likely end at the U.S. Supreme Court.  The three-judge panel will decide whether to keep, overturn, or alter a ruling from U.S. District Court […]

Anti-abortion organizations urge U.S. Supreme Court to keep limits on abortion pill

BY: - April 18, 2023

WASHINGTON — Anti-abortion medical organizations on Tuesday urged the U.S. Supreme Court to maintain a lower court ruling that would push prescribing and administration of the abortion pill back to pre-2016 instructions, ending mail orders, while an ongoing legal case works through the appeals process. Meanwhile, more members of Congress lined up on either side […]

Biden after Texas ruling vows he will fight to ensure access to abortion pill

BY: - April 8, 2023

WASHINGTON — President Joe Biden pledged to defend access to medication abortion and the Food and Drug Administration’s authority to approve pharmaceuticals after a federal judge in Texas on Friday ruled the abortion pill should be pulled from the market. Biden also keyed in on the 2024 elections in his response, saying “the only way […]

Infant formula crisis could recur, former FDA official tells Congress

BY: - March 28, 2023

WASHINGTON — U.S. lawmakers on Tuesday debated if enough has changed to prevent a repeat of the infant formula shortage, more than a year after a nationwide crisis began. The U.S. House Oversight and Accountability Committee’s Subcommittee on Health Care and Financial Services heard from two experts that while the U.S. Food and Drug Administration […]